These experiments demonstrate that the inactivation of survival effector p-AKT leads to the rapid release of accumulated apoptotic potential in EGFR-addicted cancer cells, which may be an important reason that leads to the sensitivity of tumor cells to drugs that target the addicted oncogene EGFR. This evidence concerns the gene EGFR and cancer.